Comparing two pacing methods to prevent persistent atrial fibrillation
Official title: Physiological Ventricular Pacing Versus Managed Ventricular Pacing for Persistent Atrial Fibrillation Prevention in Patients With Prolonged Atrioventricular Interval: a Multicenter RCT
Run by Quovadis Associazione · NCT05367037 · Data updated 2026-11-12
This study is testing whether a new way of pacing the heart can help people with certain heart conditions avoid long-term atrial fibrillation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 640 (estimated) |
| Sponsor | Quovadis Associazione Academic / other |
| Locations | 1 site (Rovigo, Veneto) |
| Status | Recruiting |
| Started | July 27, 2022 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | May 11, 2025 |
| Trial ID | NCT05367037 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 18 and older with prolonged atrioventricular intervals and indications for pacemaker implantation due to sinus node disease or paroxysmal second-degree AV block.
✕Probably not a fit
Patients who may not benefit include those with severe valvular heart disease, a history of long-standing persistent atrial fibrillation, or those requiring other cardiac devices.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective, randomized study aims to evaluate the effectiveness of physiological ventricular pacing compared to managed ventricular pacing in preventing persistent atrial fibrillation in patients with prolonged atrioventricular intervals. Participants will be randomly assigned to one of the two pacing methods, with the primary endpoint assessed by the pacemaker's internal diagnostic algorithm. The study focuses on patients with sinus node disease or paroxysmal second-degree AV block who require pacing. If successful, this approach could significantly reduce the occurrence of persistent atrial fibrillation in this patient population.
Why it matters
Potential benefit: If successful, this study could provide a more effective pacing method that reduces the risk of persistent atrial fibrillation in patients with specific heart conditions.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving pacing techniques, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 18 years older patients, able to express Informed Consent, with prolonged atrioventricular interval (PR\>180 ms) and one of the following indications for PM implantation according to current guidelines: * Sinus node disease. * Paroxysmal type1or 2 second-degree AV-block. Exclusion Criteria: * Candidacy for implantable cardioverter-defibrillator or cardiac resynchronization therapy device implantation. * Severe grade mitral or aortic regurgitation/stenosis. * Atrial fibrillation ablation (left pulmonary veins). * Cardiac surgery \< 3 months before PM implantation. * History of long-standing persistent AF. * Permanent third-degree AV block. * Participation in another clinical trial in the past 3 months. * Pregnancy or intention to become pregnant. * Life expectancy of \< 3 years.
Where it's running
-
Elettrofisiologia, Cardiologia, Ospedale di Rovigo
Rovigo, Veneto, Italy Recruiting
Study contacts
- Principal investigator: Gianni Pastore, MD — Cardiology Unit, "S.Maria della Misericordia" Hospital, Rovigo, Italy
- Study coordinator: Gianni Pastore, MD
- Email: gianni.pastore@aulss5.veneto.it
- Phone: +39 (339) 754-4514
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Left bundle area pacing with Closed Loop Stimulation in dual‑chamber pacemakers
This study tests whether a dual‑chamber pacemaker using left bundle area pacing and Closed Loop Stimulation can reduce device‑detected atrial fibrillation over 24 months in patients with sinus node disease and AV conduction issues.
-
Evaluating different approaches to cardiac pacing in patients
This study is testing different ways to place pacemakers in adults to see which methods work best and are safest for patients needing heart support.
-
Low-dose dobutamine stress echo to predict benefit from cardiac contractility modulation in advanced heart failure
This project tests whether a low-dose dobutamine stress echocardiogram can help predict which adults with symptomatic systolic heart failure will improve after receiving a Cardiac Contractility Modulation (CCM) implant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.